CONTACT US
Events
Events

Boston Biopharma Leadership Forum:
The Future of Access and Value in a Changing Market

Request an invitation to an exclusive leadership forum bringing together biopharma executives to discuss the future of access, value, and commercialization.

Wednesday, Nov 4

Boston, MA

Biopharma LP Photo

Request an Invitation Today

Market access leaders are navigating a rapidly changing landscape shaped by evolving definitions of value, increasing pricing and reimbursement pressures, expanding stakeholder influence, and emerging technologies. 

The Boston Biopharma Leadership Forum convenes a select group of market access, evidence, and commercialization leaders for an interactive discussion on the trends transforming healthcare decision-making and what organizations must do to remain competitive in the years ahead. 

Attendance is limited to create a collaborative environment and meaningful peer-to-peer discussion. Complete the form below to request consideration for this event. 

MEET THE EXPERTS DRIVING THE DISCUSSION

Greg Gregory_Small (1) Greg Gregory B&W

Greg Gregory, PhD

EVP,
Partner

Andrew Cournoyer 2_AQ_full Andrew Cournoyer BW

Andrew Cournoyer

SVP, Head,
Access Experience Team

Charline Shan_SQ Charline Shan_SQ_BW

Charline Shan, RPh, MPH

SVP,
US Access Strategy & Analytics

ABOUT THE EVENT

Participants will explore:

  • Navigating pricing pressures and policy change

  • Defining value in a changing healthcare landscape

  • Leveraging evidence to drive access and differentiation

    Leveraging evidence to drive access and differentiation

  • AI's role in the future of evidence

  • Understanding today's evolving access stakeholders

Why Attend?

  • Executive-level discussion with industry peers

  • Interactive panel and audience participation

  • Actionable perspectives on the evolving access landscape

  • Networking with biopharma market access and evidence leaders

  • Food, drinks, and informal conversation before and after the discussion

Intended Audience

This event is intended for senior-level professionals across:

  • Market Access

  • HEOR & RWE

  • Value & Evidence Strategy

  • Pricing & Reimbursement

  • Commercial Strategy

  • Launch Excellence

  • Medical Affairs Leadership

Explore our blog

Prelaunch Product Evaluations: When Label-Based Assumptions Don't Tell the Whole Story

Prelaunch Product Evaluations: When Label-Based Assumptions Don't Tell the Whole Story

September 25, 2026

Mechanism of Action: Step Up & Be Heard in Rare Disease

Mechanism of Action: Step Up & Be Heard in Rare Disease

In a crowded market, your drug’s mechanism of action (MOA) is more than a scientific formality – it’s strategic....

September 14, 2026

Allowing Access Versus Driving Access: A New Challenge for Health Systems

Allowing Access Versus Driving Access: A New Challenge for Health Systems

Author: Kelly Gaffney, PharmD, BCOP, DPLA, Senior Director, Access Experience Team

September 11, 2026